Home
Clinical Resources Search
PQI: Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

Download PQI pdf

Last Updated: November 13, 2023

By: Julianne Darling, PharmD

About this PQI

This PQI will examine the use of olanzapine (Zyprexa®) in the treatment of chemotherapy induced nausea and vomiting (CINV).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Implementing Reflex BRAF Testing in Metastatic Colorectal Cancer

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

S10 E13: Oncology Unfiltered: AI and the Future of Cancer Care

S10 E12: Inside GU Oncology with Uromigos Co-Host

S10 E10: Clearing the Fog: A Clinical Look at Chemo Brain

S10 E11: Your Best Meeting Ever

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Understanding Nausea and Vomiting During Cancer Treatment

PQI: Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

PQI: Granisetron Transdermal System (Sancuso®) for Chemotherapy Induced Nausea and Vomiting

PQI: Chemotherapy-Induced Nausea and Vomiting

PQI: Netupitant/Fosnetupitant and Palonosetron (Akynzeo®) for Chemotherapy-Induced Nausea and Vomiting

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

Cyclophosphamide, Bortezomib, and Dexamethasone

Tacrolimus

Pembrolizumab and Paclitaxel